Macrophage phagocytosis (Lymphatic system)

Lymphatic system / macrophage phagocytosis refers to the biological process by which specialized macrophages residing within lymphatic tissues, such as the lymph nodes and spleen, identify and engulf cellular debris, pathogens, and malignant cells. This process is a critical component of the innate immune system and serves as a vital bridge to adaptive immunity through antigen processing and presentation to T and B cells. In the context of oncology, tumor cells often evade this clearance by overexpressing anti-phagocytic signals, most notably CD47, which interacts with the SIRPα receptor on macrophages to deliver a "don't eat me" signal. Therapeutic strategies targeting this process include the development of checkpoint inhibitors that block the CD47-SIRPα axis, thereby enhancing the ability of macrophages to clear metastatic cells within the lymphatic network. Additionally, this physiological mechanism is exploited in diagnostic medicine, where radiolabeled colloids or targeted ligands (e.g., Tilmanocept) are administered to map sentinel lymph nodes via their sequestration by resident macrophages.

Other names

Lymphatic macrophage uptakePhagocytosis in lymph nodesSubcapsular sinus macrophage phagocytosisReticuloendothelial system uptake

Modulation of phagocytic activity through the blockade of inhibitory checkpoints (e.g., CD47-SIRPα axis) or the activation of pro-phagocytic pathways (e.g., Fc receptor-mediated antibody-dependent cellular phagocytosis), as well as the passive or ligand-mediated uptake of diagnostic agents by lymphatic macrophages.